ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,943Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 2094

$787K Total Retail Price of All Prescriptions

Rank: 182 out of 2094

332 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 11,755 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
WARFARIN SODIUM 653 605 1 11
LEVOTHYROXINE SODIUM 512 478 2 3
OMEPRAZOLE 395 355 3 4
SIMVASTATIN 360 355 4 1
FUROSEMIDE 360 342 4 6
DONEPEZIL HCL 304 304 6 20
NAMENDA 301 301 7 32
AMLODIPINE BESYLATE 290 282 8 2
FAMOTIDINE 235 199 9 34
METOPROLOL TARTRATE 228 221 10 10
MIRTAZAPINE 206 176 11 43
POTASSIUM CHLORIDE 188 175 12 24
SERTRALINE HCL 174 174 13 26
LISINOPRIL 166 158 14 7
MUPIROCIN 146 101 15 117
ESCITALOPRAM OXALATE 137 128 16 46
GABAPENTIN 131 123 17 23
HYDROCHLOROTHIAZIDE 131 127 17 12
METOPROLOL SUCCINATE 125 125 19 9
LOSARTAN POTASSIUM 124 110 20 17
DIGOXIN 122 115 21 51
METFORMIN HCL 122 98 21 8
LIDODERM 118 117 23 59
ISOSORBIDE MONONITRATE ER 117 117 24 57
GLIPIZIDE 113 113 25 82
CARVEDILOL 112 105 26 19
OXYCODONE-ACETAMINOPHEN 112 72 S2 26 40
ATORVASTATIN CALCIUM 111 111 28 5
DIVALPROEX SODIUM 109 92 29 69
FENTANYL 108 88 S2 30 68
LACTULOSE 104 55 31 65
CYMBALTA 103 90 32 61
SANTYL 102 63 33 114
IPRATROPIUM BROMIDE 100 100 34 169
ZOLPIDEM TARTRATE 96 82 35 14
PANTOPRAZOLE SODIUM 95 94 36 37
NOVOLOG 95 91 36 116
TAMSULOSIN HCL 89 75 38 29
NEXIUM 87 61 39 16
PREDNISONE 86 84 40 54
CITALOPRAM HBR 84 77 41 47
VESICARE 82 68 42 152
SPIRONOLACTONE 80 73 43 93
CLOPIDOGREL 80 80 43 22
TRAMADOL HCL 79 62 45 33
QUETIAPINE FUMARATE 77 77 46 71
ALBUTEROL SULFATE 76 74 47 90
BACLOFEN 76 41 47 166
ALENDRONATE SODIUM 75 75 49 30
PAROXETINE HCL 74 72 50 77
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 59 50 182
EXELON 71 71 52 111
AMIODARONE HCL 68 68 53 175
NITROGLYCERIN PATCH 66 66 54 101
DILTIAZEM 24HR CD 64 46 55 110
ATENOLOL 63 63 56 21
ADVAIR DISKUS 62 62 57 36
RAMIPRIL 62 62 57 48
CARBIDOPA-LEVODOPA 61 57 59 102
NITROFURANTOIN MONO-MACRO 58 55 60 265
OLANZAPINE 58 46 60 113
LANTUS 58 56 60 66
CLONIDINE HCL 58 46 60 62
PLAVIX 54 53 64 38
LATANOPROST 54 54 64 153
RISPERIDONE 54 52 64 56
DOXAZOSIN MESYLATE 54 54 64 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.